We have successfully licensed many technologies, ranging from Breast Cancer Serum markers, mouse models of cancer, monoclonal antibodies, RNAi libraries to software.
If you are interested in this opportunity, or like to know about our other current opportunities, please contact Dr. Koen Verhoef (telephone: +31 20 512 1998, email: k.verhoef@nki.nl).